Who's Who Legal Thought Leaders (Global 2020) - "Healthcare"
"Stefan Kohler is a regulatory specialist who assists domestic and international clients in navigating healthcare and life sciences regulations." He is listed as Global Elite Thought Leader.
Who's Who Legal Thought Leaders (Switzerland 2020) - "Patents"
"Stefan Kohler possesses strong experience in IP and technology law, and is active in a plethora of industries including biotech, cosmetics and healthcare."
Who's Who Legal Thought Leaders (Switzerland 2020) - "Life Sciences"
"Stefan Kohler is a standout lawyer distinguished for his expertise in IP law. He brings significant value to clients due to his insights into the biotech, healthcare and pharma markets."
Legal 500 (EMEA 2020) - "Healthcare and Life Sciences"
"VISCHER has a strong track record in transactions in the life sciences space, in which it acts for companies, entrepreneurs and investors alike. It is also well versed in advising clients on compliance matters, administrative procedures and other regulatory matters. Stefan Kohler has longstanding experience in the sector and further advises on IP and technology law. He jointly leads the practice alongside Matthias Staehelin in Basel, who is a key contact for M&A, IPOs and financings in this space. Christian Wyss, also in Basel, has considerable knowledge in setting up contracts and assisting start-ups."
Legal 500 (EMEA 2019) - "Healthcare and Life Sciences" - Tier 1
"VISCHER is renowned for its expertise in corporate, commercial, transactional, regulatory and patent-related healthcare and biotech matters. Matthias Staehelin assisted Medartis with its initial public offering on the SIX Swiss Exchange, while Stefan Kohler acted for Novo Nordisk Pharma in its appeal against a pricing decision made by the Swiss Federal Office of Public Health concerning the client's type-two diabetes product. Christian Wyss advised Lundbeck on its €905m acquisition of Prexton Therapeutics."
Legal 500 (EMEA 2018) - "Healthcare and life sciences" - Tier 1
"Vischer provides transactional, financing, capital markets, product launch and regulatory advice to health and life sciences industry clients and further represents them in contentious matters. The practice assisted JSR Corporation with its acquisition of Selexis and advised Axovant Sciences on its debt financing agreement with Hercules Capital. Stefan Kohler jointly heads the practice with Matthias Staehelin; Christian Wyss is another name to note."